Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03056001
Brief Title: Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

First Submitted : February 3, 2017
First Submitted that Met QC Criteria : February 15, 2017
First Posted : February 16, 2017

Last Update Submitted that Met QC Criteria : November 17, 2020
Last Update Posted : November 18, 2020